Autor(en): Murano, Chihiro
Igarashi, Akira
Yamauchi, Keiko
Inoue, Sumito
Watanabe, Masafumi
Titel: Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma
Sprache (ISO): en
Zusammenfassung: A 20-year-old woman was diagnosed with stage 4 lung adenocarcinoma with an epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation. Although the patient underwent chemotherapy, her lesions progressed. Liquid biopsy for EGFR T790M mutation showed negative results. After administering osimertinib, reduction of the lesions at the primary site was observed, and the patient’s respiratory condition improved. Previous reports showing successful treatment of EGFR exon 20 insertion-positive lung adenocarcinoma with the standard osimertinib dose of 80 mg are limited. The present case demonstrated that osimertinib could be a possible treatment option for EGFR exon 20 insertion-positive lung adenocarcinoma.
Schlagwörter: Lung cancer
Adenocarcinoma
EGFR exon 20 insertion gene mutation
Osimertinib
URI: http://hdl.handle.net/2003/39141
http://dx.doi.org/10.17877/DE290R-21059
Erscheinungsdatum: 2019-10-07
Rechte (Link): http://creativecommons.org/licenses/by/4.0/
Enthalten in den Sammlungen:Case Reports

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
Inoue_07102019_proof.pdfDNB617.38 kBAdobe PDFÖffnen/Anzeigen


Diese Ressource ist urheberrechtlich geschützt.



Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons Creative Commons